U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07691489) titled 'A Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer' on July 02.
Brief Summary: The purpose of this study is find out whether the combination of trastuzumab deruxtecan (T-DXd) and cetuximab is an effective treatment for participants with metastatic and/or unresectable colorectal cancer that expresses low levels of HER2 and that has gotten worse after receiving standard treatment.
Study Start Date: Aug., 2026
Study Type: INTERVENTIONAL
Condition:
Colorectal Cancer
Adenocarcinoma of the Colon
Adenocarcinoma of the Rectum
Intervention:
DRUG: Fam-Trastuzumab Deruxtecan-Nxki
The investigational...